What it is
A blood-forming (hematopoietic) stem cell transplant replaces a person's blood-forming cells with cells from a donor or, in some situations, from the person's own body. The cells can come from bone marrow, circulating blood or cord blood. This is the stem cell use that is clearly FDA-approved, for certain cancers and blood disorders.
Whether a transplant is considered at all depends on the specific condition, its stage, overall health and many other factors. Only a licensed clinician, usually a hematologist or transplant physician, can decide after a full evaluation whether it is appropriate. Not everyone with a blood condition is a candidate, and it is never a promise of a particular outcome.
It is important to keep this separate from other products. Stem cell, mesenchymal stem cell (MSC), bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging or hair loss are generally not FDA-approved for those uses. The FDA has warned the public about unapproved stem cell clinics and products.
How it’s traditionally been approached
Transplant care has traditionally been delivered at specialized medical centers by a team that may include hematologists, oncologists, transplant physicians, nurses, pharmacists, social workers and dietitians. The process generally begins with an evaluation, a search for a suitable donor or a plan to use the person's own cells, and preparation before the transplant.
After a transplant, people are typically monitored closely for a period of time. Teams watch for complications such as infection, immune reactions between donor and recipient cells, and side effects of the medicines used. Because the risks are real, this care is generally supervised by clinicians experienced in it.
Some people are also offered participation in a registered clinical trial, which is a legitimate route to experimental care. Trials can be searched through ClinicalTrials.gov, and a transplant team can help explain whether a trial might be a reasonable question to raise.
How the right provider may help
The right provider may help you understand your diagnosis, whether a transplant is among the options discussed for your situation, and what the process generally involves. A first visit is usually a conversation: reviewing your history, test results and goals, and answering your questions. Bringing a trusted person to take notes can be helpful.
Good questions to ask include: Is this an FDA-approved use of the product? What exactly will be given, and where does it come from? What are the specific risks for me, and what is a realistic chance of benefit? What are the alternatives, including watchful waiting or doing nothing? What is the total cost, including follow-up care? Can I take time, get a second opinion, or walk away?
Informed consent should cover the exact product and its FDA status, specific risks, realistic chance of benefit, alternatives, total cost disclosure and your right to say no. This page is not a consent form and cannot replace the discussion with your care team. Red flags include guarantees of results, words like "cure" or "regrow," refusal to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion.
The whole-person view
Body, mind and stress affect each other. A serious blood diagnosis and a demanding treatment process can bring fear, fatigue, sleep trouble and a sense of uncertainty, and those feelings can in turn affect how the body feels day to day. Looking after the whole person is a reasonable part of care alongside medical treatment.
Some people find body-based support, such as the approaches offered through Somatic Experiences, helpful for working with stress held in the body. Others value talk therapy, which may be found through Therapists.plus, to process worry, grief or life changes. These are supportive options that may complement, never replace, the guidance of your medical team.
Somatic Experiences: nervous system regulation →Somatic Experiences: embodiment and movement →Therapists.plus: mind body connection →
Keep in mind
- Blood cancers and blood disorders are serious conditions, and licensed professionals should guide all care decisions.
- Blood-forming transplants for certain conditions are FDA-approved, but other stem cell or exosome products marketed for joints, skin, anti-aging or hair loss are generally not, and reported risks include infection, immune reaction, tumor formation at the injection site, and permanent injury from unapproved products injected into the eye or spine.
- Treatment abroad (medical tourism) carries materially higher risk because safety, sourcing and regulatory standards differ and complications are harder to address from a distance; a vetted domestic provider or a registered clinical trial is a safer first step. Suspected problems can be reported through the FDA's MedWatch program and to your state medical board.
- For emergencies call 911; in a crisis call or text 988.
For your safety, sensitive situations are best guided by licensed professionals.
Providers who often help
Get matched privatelyFrequently asked questions
Is stem cell therapy safe for leukemia and lymphoma?
Blood-forming stem cell transplants from bone marrow or cord blood are an FDA-approved use for certain cancers and blood disorders, but they carry real risks such as infection and immune reactions. Whether one is appropriate depends on your condition and health, and only a licensed transplant team can decide after an evaluation.
Is stem cell therapy for sickle cell disease FDA-approved?
Blood-forming stem cell transplant is an established approach that may be considered for certain people with sickle cell disease. Eligibility depends on individual factors, so ask a hematologist or transplant specialist whether it applies to your situation and which specific products or procedures are FDA-approved.
What should I ask my transplant team?
Ask what the procedure involves, the FDA status of everything used, specific risks, a realistic chance of benefit, alternatives including doing nothing, total costs and what follow-up looks like. Also ask about registered clinical trials and whether a second opinion is welcome.
What are red flags of an unsafe stem cell clinic?
Red flags include guarantees of results, "cure" or "regrow" claims, refusing to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion. The FDA has warned the public about unapproved stem cell clinics and products, so slow down and consult a licensed clinician.
How do I report a problem with a stem cell product or clinic?
You can report a suspected safety problem through the FDA's MedWatch safety reporting program and file a concern with your state medical board. Seek medical care first if you are unwell, and call 911 in an emergency.
Can I find a legitimate clinical trial?
Yes, registered clinical trials can be searched on ClinicalTrials.gov, and they are a legitimate route to experimental care. Discuss any trial with your treating team to understand its purpose, risks and whether you may qualify.
Educational resource. Safe Stem Cells shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.